Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Operating Expenses | 30,913 | 24,942 | 27,402 | 17,909 | 16,117 |
| Operating Income | -30,913 | -24,942 | -27,402 | -17,909 | -16,117 |
| Other Income | 512 | 414 | 208 | 218 | 201 |
| Pre-tax Income | -30,401 | -24,528 | -27,194 | -17,691 | -15,916 |
| Net Income Continuous | -30,401 | -24,528 | -27,194 | -17,691 | -15,916 |
| Net Income | $-30,401 | $-24,528 | $-27,194 | $-17,691 | $-15,916 |
| EPS Basic Total Ops | -1.14 | -0.96 | -1.28 | -0.82 | -0.77 |
| EPS Basic Continuous Ops | -1.14 | -0.96 | -1.28 | -0.82 | -0.77 |
| EPS Diluted Total Ops | -1.14 | -0.96 | -1.28 | -0.82 | -0.77 |
| EPS Diluted Continuous Ops | -1.14 | -0.96 | -1.28 | -0.82 | -0.77 |
| EPS Diluted Before Non-Recurring Items | -1.14 | -0.96 | N/A | N/A | N/A |
| EBITDA(a) | $-30,840 | $-24,845 | $-27,249 | $-17,731 | $-15,964 |